Search This Blog

Monday, July 29, 2019

Bristol-Myers’ Celgene buy OK’d in Europe

The European Commission has signed off on Bristol-Myers Squibb’s (BMY-0.2%) previously announced acquisition of Celgene (CELG +0.1%). The transaction should close by year-end or early 2020.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)